Top compounds associated with response to SPRYD3


Feature Type Standardized
Nominal ANOVA
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.1 0.0005
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA RO-3306 GDSC1000 pan-cancer AAC 0.12 0.0006
mRNA niclosamide CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.17 0.0007
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC -0.11 0.0008
Download CSV